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Implantable Drug Therapy Device - A Concept 
S
The problem: 
There is need for a reliable drug infusor pump that 
can be implanted within the patient and requires no 
maintenance or attention for long periods of time. 
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The solution: 
A small, rechargeable, implantable infusor which 
contains a fluid medicament stored under pressure 
dispenses the fluid continuously through a catheter. 
How it's done: 
The design envisioned for the implantable device is 
generally in the form of a stainless steel cylinder about 
2.5 cm in diameter and 8 to 10 cm in length. The so-
lution reservoir (about 40 ml) is a silicone rubber bag 
mounted within the cylinder and equipped with a 
special resealable side-seal as indicated in the dia-
gram. Gas at high pressure in a reservoir passes 
through a flow regulator and squeezes the bag; since
the flow rate of gas is controlled, the solution within 
the bag can be dispensed directly through a catheter. 
At flow rates of 4 to 5 ml per day, the reservoir will 
need to be filled once a week; refilling can be readily 
accomplished with a hypodermic needle. As shown in 
the diagram, resealable discs are available which can 
resist about 70 punctures; thus, the implantable de-
vice can be used for as much as one year before it 
needs to be replaced. A check valve allows rapid re-
turn of gas to the reservoir when the fluid in the im-
planted device is replenished. 
The body of the implantable device is covered by a 
pliable silicone rubber sheath attached to a suture 
pad for securing the device. 
Note: 
Requests for further information may be directed 
to:
Technology Utilization Officer 
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Patent status: 
NASA has decided not to apply for a patent. 
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